Skip to main content

Advertisement

Log in

Exparel for Postoperative Pain Management: a Comprehensive Review

  • Other Pain (N Vadivelu and AD Kaye, Section Editors)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Multimodal pain management is the most effective way to treat postsurgical pain. However, the use of opioids for acute pain management has unfortunately been a significant contributor to the current opioid epidemic. The use of opioids should be limited and only considered a “rescue” pain medication after other modalities of pain management have been utilized.

Recent Findings

It may be difficult to curtail the use of opioids in the treatment of chronic pain; however, in the postsurgical setting, there is compelling evidence that an opioid-centric analgesic approach is not necessary for good patient outcomes and healthcare cost benefits. Opioid-related adverse effects are the leading cause of preventable harm in the hospital setting. After the realization in recent years of the many harmful effects of opioids, alternative regimens including the use of multimodal analgesia have become a standard practice in acute pain management. Exparel, a long-lasting liposomal bupivacaine local anesthetic agent, has many significant benefits in the management of postoperative pain.

Summary

Overall, the literature suggests that Exparel may be a significant component for postoperative multimodal pain control owing to its efficacy and long duration of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30:149–60. https://doi.org/10.1185/03007995.2013.860019.

    Article  Google Scholar 

  2. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–25. https://doi.org/10.1016/S0140-6736(06)68700-X.

    Article  Google Scholar 

  3. Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North Am. 2005;23:21–36. https://doi.org/10.1016/j.atc.2004.11.013.

    Article  Google Scholar 

  4. Coley KC, Williams BA, DaPos SV, Chen C, Smith RB. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth. 2002;14:349–53.

    Article  Google Scholar 

  5. Cousins MJ, Power I, Smith G. 1996 Labat lecture: pain--a persistent problem. Reg Anesth Pain Med. n.d.;25:6–21.

  6. •• Smith J, Probst S, Calandra C, Davis R, Sugimoto K, Nie L, et al. Enhanced recovery after surgery (ERAS) program for lumbar spine fusion. Perioper Med. 2019;8:4. https://doi.org/10.1186/s13741-019-0114-2This is a good paper discussing ERAS for lumbar spine fusion.

  7. Spanjersberg WR, van Sambeeck JDP, Bremers A, Rosman C, van Laarhoven CJHM. Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme. Surg Endosc. 2015;29:3443–53. https://doi.org/10.1007/s00464-015-4148-3.

    Article  CAS  Google Scholar 

  8. Chiu C, Aleshi P, Esserman LJ, Inglis-Arkell C, Yap E, Whitlock EL, et al. Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol. 2018;18:41. https://doi.org/10.1186/s12871-018-0505-9.

    Article  Google Scholar 

  9. •• Coppens SJR, Zawodny Z, Dewinter G, Neyrinck A, Balocco AL, Rex S. In search of the Holy Grail: poisons and extended release local anesthetics. Best Pract Res Clin Anaesthesiol. 2019;33:3–21. https://doi.org/10.1016/j.bpa.2019.03.002.  This is a good paper discussing poisons and extended release local anesthetics.

  10. Jacob BC, Peasah SK, Shogbon AO, Perlow ER. Postoperative pain management with liposomal bupivacaine in patients undergoing orthopedic knee and hip arthroplasty at a community hospital. Hosp Pharm. 2017;52:367–73. https://doi.org/10.1177/0018578717715382.

    Article  CAS  Google Scholar 

  11. Hutchins J, Delaney D, Vogel RI, Ghebre RG, Downs LS, Carson L, et al. Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: a prospective randomized controlled study. Gynecol Oncol. 2015;138:609–13. https://doi.org/10.1016/j.ygyno.2015.06.008.

    Article  CAS  Google Scholar 

  12. •• Liu Y, Zeng Y, Zeng J, Li M, Wei W, Shen B. The efficacy of liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty: an updated meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2019;20:306. https://doi.org/10.1186/s12891-019-2660-7. This is a good meta-analysis discussing liposomal bupivacaine compared with traditional peri-articular injection for pain control following total knee arthroplasty.

  13. Malik O, Kaye AD, Kaye A, Belani K, Urman RD. Emerging roles of liposomal bupivacaine in anesthesia practice. J Anaesthesiol Clin Pharmacol. n.d.;33:151–6. https://doi.org/10.4103/joacp.JOACP_375_15.

  14. • Lee CY, Robinsom DA, Johnson CA, Zhang Y, Wong J, Joshi DJ, et al. A randomized controlled trial of liposomal bupivacaine parasternal intercostal block for sternotomy. Ann Thorac Surg. 2019;107:128–34. https://doi.org/10.1016/j.athoracsur.2018.06.081. This is a good randomized controlled trial discussing liposomal bupivacaine parasternal intercostal block for sternotomy.

  15. Hernandez MC, Finnesgard EJ, Leiting JL, Franssen B, Saleem H, Kendrick ML, et al. Transversus abdominis plane blocks with liposomal bupivacaine after open major hepatectomy is associated with reduced early patient-reported pain scores and opioid administration. Surg (United States). 2018;164:1251–8. https://doi.org/10.1016/j.surg.2018.07.023.

    Article  Google Scholar 

  16. • Yayac M, Li WT, Ong AC, Courtney PM, Saxena A. The efficacy of liposomal bupivacaine over traditional local anesthetics in periarticular infiltration and regional anesthesia during total knee arthroplasty: a systematic review and meta-analysis. J Arthroplast. 2019;34:2166–83. https://doi.org/10.1016/j.arth.2019.04.046. This is a good meta-analysis discussing the efficacy of liposomal bupivacaine over traditional local anesthetics in periarticular infiltration and regional anesthesia during total knee arthroplasty.

  17. • Kolade O, Patel K, Ihejirika R, Press D, Friedlander S, Roberts T, et al. Efficacy of liposomal bupivacaine in shoulder surgery: a systematic review and meta-analysis. J Shoulder Elb Surg. 2019;28:1–11. https://doi.org/10.1016/j.jse.2019.04.054This is a good systematic review discussing the efficacy of liposomal bupivacaine in shoulder surgery.

  18. • Zhao B, Ma X, Zhang J, Ma J, Cao Q. The efficacy of local liposomal bupivacaine infiltration on pain and recovery after total joint arthroplasty. Medicine (Baltimore). 2019;98:1–7. This is a good paper discussing local liposomal bupivacaine infiltration on pain and recovery after total joint arthroplasty.

  19. Sun H, Li S, Wang K, Zhou J, Wu G, Fang S, et al. Do liposomal bupivacaine infiltration and interscalene nerve block provide similar pain relief after total shoulder arthroplasty: a systematic review and meta-analysis. J Pain Res. 2018;11:1889–900. https://doi.org/10.2147/JPR.S177716.

    Article  CAS  Google Scholar 

  20. Dysart SH, Barrington JW, Del Gaizo DJ, Sodhi N, Mont MA. Local infiltration analgesia with liposomal bupivacaine improves early outcomes after total knee arthroplasty: 24-hour data from the pillar study. J Arthroplast. 2019;34:882–6. https://doi.org/10.1016/j.arth.2018.12.026 LK - http://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=15328406&id=doi:10.1016%2Fj.arth.2018.12.026&atitle=Local+Infiltration+Analgesia+With+Liposomal+Bupivacaine+Improves+Early+Outcomes+After+Total+Knee+Arthroplasty%3A+24-Hour+Data+From+the+PILLAR+Study&stitle=J.+Arthroplasty&title=Journal+of+Arthroplasty&volume=&issue=&spage=&epage=&aulast=Dysart&aufirst=Stanley+H.&auinit=S.H.&aufull=Dysart+S.H.&coden=JOARE&isbn=&pages=-&date=2019&auinit1=S&auinitm=H.

    Article  Google Scholar 

  21. Zhang X, Yang Q, Zhang Z. The efficiency and safety of local liposomal bupivacaine infiltration for pain control in total hip arthroplasty. Medicine (Baltimore). 2017;96:1–11.

    Google Scholar 

  22. Ferlas B. Liposomal bupivacaine: a new option for postoperative pain. US Pharm. 2015.

  23. Hamilton TW, Athanassoglou V, Trivella M, Strickland LH, Mellon S, Murray D, et al. Liposomal bupivacaine peripheral nerve block for the management of postoperative pain. Cochrane Database Syst Rev. 2016;2016. https://doi.org/10.1002/14651858.CD011476.pub2.

  24. Jacob BC, Peasah SK, Shogbon AO, Perlow ER. Postoperative pain management with liposomal bupivacaine in patients undergoing orthopedic knee and hip arthroplasty at a community hospital. Hosp Pharm. 2017;52:367–73. https://doi.org/10.1177/0018578717715382.

    Article  CAS  Google Scholar 

  25. Jones CL, Mba DO, Ms DDG, Fischer JR, Do KL, Hernandez SL. Liposomal bupivacaine efficacy for postoperative pain following posterior vaginal surgery. Am J Obstet Gynecol. 2018;219:500.e1–8. https://doi.org/10.1016/j.ajog.2018.09.029.

    Article  CAS  Google Scholar 

  26. Zlotnicki JP, Urish KL, Hamlin BR, Plakseychuk AY, Levison TJ, Rothenberger SD. Liposomal bupivacaine vs plain bupivacaine in periarticular injection for control of pain and early motion in total knee arthroplasty: a randomized, prospective study. J Arthroplast. 2018;33:2460–4. https://doi.org/10.1016/j.arth.2018.03.014.

    Article  Google Scholar 

  27. Namdari S, Nicholson T, Abboud J, Lazarus M, Steinberg D, Williams G. Interscalene block with and without intraoperative local infiltration with liposomal bupivacaine in shoulder arthroplasty. J Bone Jt Surg. 2018;100:1373–8.

    Article  Google Scholar 

  28. Mazloomdost D, Pauls R, Hennen E, Yeung J, Smith B, Kleeman S, et al. Liposomal bupivacaine decreases pain following retropubic sling placement: a randomized placebo-controlled trial. Am J Obstet Gynecol. 2017;598:20–3.

    Google Scholar 

  29. Brown L, Weir T, Shasti M, Yousaf O, Yousaf I, Tannous O, et al. The efficacy of liposomal bupivacaine in lumbar spine surgery. Intern J Spine Surg. 2018;12:434–40. https://doi.org/10.24966/scti-7284/100005.

    Article  Google Scholar 

  30. Davidovitch R, Goch A, Driesman A, Konda S, Pean C, Egol K. The use of liposomal bupivacaine administered with standard bupivacaine in ankle fractures requiring open reduction internal fixation. J Orthop Trauma. 2017;31:434–9. https://doi.org/10.1097/bot.0000000000000862.

    Article  Google Scholar 

  31. Colibaseanu DT, Osagiede O, Merchea A, Ball CT, Bojaxhi E, Panchamia JK, et al. Randomized clinical trial of liposomal bupivacaine transverse abdominis plane block versus intrathecal analgesia in colorectal surgery. Br J Surg. 2019;106:692–9. https://doi.org/10.1002/bjs.11141.

    Article  CAS  Google Scholar 

  32. Hyland SJ, Deliberato DG, Fada RA, Romanelli MJ, Collins CL, Wasielewski RC. Liposomal bupivacaine versus standard periarticular injection in total knee arthroplasty with regional anesthesia: a prospective randomized controlled trial. J Arthroplast. 2019;34:488–94. https://doi.org/10.1016/j.arth.2018.11.026.

    Article  Google Scholar 

  33. Chahar P, Cummings KC III. Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res. 2012;5:257–64. https://doi.org/10.2147/JPR.S27894.

    Article  Google Scholar 

  34. B.M. I, E.R. V, A. H, H.S. M, M.D. M, J. L, et al. Safety and side effect profile of liposome bupivacaine (Exparel) in peripheral nerve blocks. Reg Anesth Pain Med 2015. doi:https://doi.org/10.1097/AAP.0000000000000283.

  35. Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28:776–88. https://doi.org/10.1007/s12325-011-0052-y.

    Article  CAS  Google Scholar 

  36. Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19:530–6. https://doi.org/10.1016/j.knee.2011.12.004.

    Article  Google Scholar 

  37. B.M. R, P. N, L.R. O, D. H, A.N. B, P.I. C, et al. The safety of EXPAREL ® (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogs. J Drug Deliv 2012. doi:https://doi.org/10.1155/2012/962101.

  38. J.B. M, R.F. P, S.A. S, G. R, A.H. K, H.H. C, et al. Multivesicular liposomal bupivacaine at the sciatic nerve. Biomaterials 2014. doi:https://doi.org/10.1016/j.biomaterials.2014.02.015.

  39. M. D, E. C, A. H, A. S, T. P, K. M, et al. Neurotoxicity of perineural vs intraneural-extrafascicular injection of liposomal bupivacaine in the porcine model of sciatic nerve block. Anaesthesia 2015. doi:https://doi.org/10.1111/anae.13189.

  40. D.E. F, M. K, P.M. G, N. Y, E. L. Liposomal bupivacaine infiltration into the transversus abdominis plane for postsurgical analgesia in open abdominal umbilical hernia repair: results from a cohort of 13 patients. J Pain Res 2014. doi:https://doi.org/10.2147/JPR.S65151.

  41. Bergese SD, Ramamoorthy S, Patou G, Bramlett K, Gorfine SR, Candiotti KA. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012. https://doi.org/10.2147/JPR.S30861.

  42. E.R. V, R. S, E. O, S.L. R. The safety of liposome bupivacaine, a novel local analgesic formulation. Clin J Pain 2014. doi:https://doi.org/10.1097/AJP.0b013e318288e1f6.

  43. Naseem A, Harada T, Wang D, Arezina R, Lorch U, Onel E, et al. Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. J Clin Pharmacol. 2012;52:1441–7. https://doi.org/10.1177/0091270011419853.

    Article  CAS  Google Scholar 

  44. Viscusi ER, Candiotti KA, Onel E, Morren M, Ludbrook GL. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med. 2012;37:616–22. https://doi.org/10.1097/AAP.0b013e318269d29e.

    Article  CAS  Google Scholar 

  45. Hadzic A, Minkowitz HS, Melson TI, Berkowitz R, Uskova A, Ringold F, et al. Liposome bupivacaine femoral nerve block for postsurgical analgesia after total knee arthroplasty. Anesthesiology. 2016;124:1372–83. https://doi.org/10.1097/ALN.0000000000001117.

    Article  CAS  Google Scholar 

  46. D.C. R, J.P. C, G.E. M, A. R-R, A.M. C, R.J. M. Posterior intercostal nerve block with liposomal bupivacaine: an alternative to thoracic epidural analgesia. Ann Thorac Surg 2015.

  47. Patel MA, Gadsden JC, Nedeljkovic SS, Bao X, Zeballos JL, Yu V, et al. Brachial plexus block with liposomal bupivacaine for shoulder surgery improves analgesia and reduces opioid consumption: results from a multicenter, randomized, double-blind. Controlled Trial Pain Med. 2019. https://doi.org/10.1093/pm/pnz103.

  48. Pacira reports positive phase 3 results for long-acting local analgesic in pediatric patients | BioTuesdays n.d. https://biotuesdays.com/2019/12/17/pacira-reports-positive-phase-3-results-for-long-acting-local-analgesic-in-pediatric-patients/ ().

  49. Day KM, Nair NM, Griner D, Sargent LA. Extended release liposomal bupivacaine injection (EXPAREL) for early postoperative pain control following pharyngoplasty. J Craniofac Surg. 2018;29:726–30. https://doi.org/10.1097/SCS.0000000000004312.

    Article  Google Scholar 

  50. Cohen B, Glosser L, Saab R, Walters M, Salih A, Zafeer-Khan M, et al. Incidence of adverse events attributable to bupivacaine liposome injectable suspension or plain bupivacaine for postoperative pain in pediatric surgical patients: a retrospective matched cohort analysis. Paediatr Anaesth. 2019;29:169–74. https://doi.org/10.1111/pan.13561.

    Article  Google Scholar 

  51. Cloyd C, Moffett BS, Bernhardt MB, Monico EM, Patel N, Hanson D. Efficacy of liposomal bupivacaine in pediatric patients undergoing spine surgery. Paediatr Anaesth. 2018;28:982–6. https://doi.org/10.1111/pan.13482.

    Article  Google Scholar 

  52. de Araújo DR, Ribeiro LN de M, de Paula E. Lipid-based carriers for the delivery of local anesthetics. Expert Opin Drug Deliv. 2019;16:701–14. https://doi.org/10.1080/17425247.2019.1629415.

    Article  CAS  Google Scholar 

  53. Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of Exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthroplast. 2014;30:325–9. https://doi.org/10.1016/j.arth.2014.09.004.

    Article  Google Scholar 

  54. Yu Z-X, Yang Z-Z, Yao L-L. Effectiveness of liposome bupivacaine for postoperative pain control in total knee arthroplasty. Medicine (Baltimore). 2018;97:e0171. https://doi.org/10.1097/MD.0000000000010171.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elyse M. Cornett.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Other Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaye, A.D., Armstead-Williams, C., Hyatali, F. et al. Exparel for Postoperative Pain Management: a Comprehensive Review. Curr Pain Headache Rep 24, 73 (2020). https://doi.org/10.1007/s11916-020-00905-4

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11916-020-00905-4

Keywords

Navigation